EPHA1 and breast cancer: The current review summarizes the results of original research articles extensively studying the mechanisms of action of newly established agents, ranging from TKIs or HAd-based vectors to immunotherapeutics and phytopharmaceuticals, and targeting diverse members of the EPH/ephrin family in BC.